Fort Myers-based NeoGenomics awarded $374K in grants

Fort Myers-based NeoGenomics Inc. is among 77 Florida firms that have been awarded more than $26 million in federal tax credits or grants under a Qualifying Therapeutic Discovery Project program.

NeoGenomics, which specializes in genetic testing for cancer, received two grants, one was for $244,479.24, and the other was for $130,000.

The discovery program is designed to encourage research and development of products that promise to significantly advance health care in the country. The program was created as part of the Patient Protection and Affordable Care Act of 2010.

The maximum award per application was $244,479.25.

To qualify, projects must show the potential to produce new cost-saving therapies, create U.S. jobs, increase the country’s competitiveness, or significantly advance the goal of curing cancer within the next 30 years.

© 2010 All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • Discuss
  • Print

Related Stories

Comments » 0

Be the first to post a comment!

Share your thoughts

Comments are the sole responsibility of the person posting them. You agree not to post comments that are off topic, defamatory, obscene, abusive, threatening or an invasion of privacy. Violators may be banned. Click here for our full user agreement.

Comments can be shared on Facebook and Yahoo!. Add both options by connecting your profiles.